IDiyas

For the Inventor, By the Inventor

Newbury Park, CA, United States of America

Bradley J Herberich

USPTO Granted Patents = 11 

 

 

Average Co-Inventor Count = 9.2

ph-index = 4

Forward Citations = 71(Granted Patents)


Company Filing History:

goldMedal11 out of 1,970 
 
Amgen Inc.
 patents

Years Active: 2010-2025

where 'Filed Patents' based on already Granted Patents

11 patents (USPTO):
1. 12214051 - Method of treating or ameliorating metabolic disorders using GLP-1 receptor agonists conjugated to antagonists for gastric inhibitory peptide receptor (GIPR) (2025-02-04),
2. 10905772 - Method of treating or ameliorating metabolic disorders using GLP-1 receptor agonists conjugated to antagonists for gastric inhibitory peptide receptor (GIPR) (2021-02-02),
3. 9394297 - Amides as pim inhibitors (2016-07-19),
4. 9346801 - Substituted 7-oxo-pyrido[2,3-d]pyrimidines and methods of use (2016-05-24),
5. 9321756 - Azole compounds as PIM inhibitors (2016-04-26),
6. 9187486 - Bicyclic pyridazine compounds as Pim inhibitors (2015-11-17),
7. 9090593 - Bicyclic compounds as Pim inhibitors (2015-07-28),
8. 8772480 - Inhibitors of PI3 kinase and/or mTOR (2014-07-08),
9. 8497269 - Phthalazine compounds as p38 map kinase modulators and methods of use thereof (2013-07-30),
10. 7759337 - Phthalazine compounds and methods of use (2010-07-20),
11. 7700593 - Imidazo- and triazolo-pyridine compounds and methods of use thereof (2010-04-20),

Title: Bradley J Herberich: Innovating Treatment for Metabolic Disorders

Introduction:

Bradley J Herberich, a prominent inventor based in Newbury Park, CA, has made significant contributions in the field of healthcare with a focus on metabolic disorders. With a total of 10 patents to his name, Herberich's innovative work is shaping the landscape of medical treatments.

Latest Patents:

Among his latest patents, one notable invention is the "Method of treating or ameliorating metabolic disorders using GLP-1 receptor agonists conjugated to antagonists for gastric inhibitory peptide receptor (GIPR)." This method revolutionizes the treatment of metabolic diseases such as type 2 diabetes, obesity, dyslipidemia, and more by utilizing a unique composition of proteins.

Another groundbreaking patent is the "Amides as Pim Inhibitors," which focuses on developing compounds that inhibit Pim-1, Pim-2, and Pim-3 protein kinase activity. These compounds hold promise in the prevention and treatment of Pim kinase-related conditions, particularly cancer.

Career Highlights:

Throughout his career, Bradley J Herberich has demonstrated a commitment to advancing medical science through innovation. His patented inventions reflect his dedication to finding novel solutions for complex healthcare challenges, especially in the realm of metabolic disorders.

Collaborations:

Herberich has collaborated with esteemed coworkers such as Andrew Stewart Tasker and Liping H Pettus. These collaborations have further enriched his research and led to groundbreaking discoveries in the field of healthcare.

Conclusion:

In conclusion, Bradley J Herberich's work as an inventor and innovator in the healthcare industry is truly commendable. His patents, including the pioneering methods for treating metabolic disorders, exemplify his dedication to improving patient outcomes and transforming the way we approach healthcare. Herberich's contributions continue to inspire advancements in the field, offering hope for better treatment options for those affected by metabolic diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…